MedTrace Logo

Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial

NCT01881919 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2015-03-24

No results posted yet for this study

Summary

The purpose of this study was to test the effect of chronic consumption of Quercetin 500 mg tablets on blood uric acid and other biomarkers in adult males.

Conditions

Interventions

DIETARY_SUPPLEMENT

Treatment

Address: Nature's Best, Century Place, Tunbridge Wells, Kent, TN2 3BE Phone:+44(0)1892 552030 Email:[email protected]

DIETARY_SUPPLEMENT

Control

Address: Fagron GmbH\&Co. KG, 22885 Barsbuttel, Germany Phone: +49(0)4067067680

Sponsors & Collaborators

  • University of Leeds

    lead OTHER

Principal Investigators

  • Gary Williamson, PhD · University of Leeds

  • Yuanlu Shi, PhD Candidate · University ofLeeds

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-04-30
Completion
2014-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881919 on ClinicalTrials.gov